• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症血浆的色谱研究。

Chromatographic studies of uremic plasma.

作者信息

Mamdani B H, Shaykh M M, Evenson M A, Dunea G

出版信息

Int J Artif Organs. 1979 Jul;2(4):187-91.

PMID:88420
Abstract

In order to characterize the spectrum of possibly toxic retention compounds in uremia we have developed a simple reproducible method of separating fractions of uremic serum by Sephadex G-15 column chromatography. This technique, which requires no prior deproteinisation and is carried out at ambient temperatures, allowed the separation of uremic serum into several well defined fractions. Subsequent thin layer chromatography (TLC) showed that each peak represented a mixture of peptides, and that there were qualitative and quantitative differences between the plasma of normal and uremic patients as well as between patients with acute renal failure and chronic renal failure.

摘要

为了描述尿毒症中可能具有毒性的潴留化合物的谱,我们开发了一种简单且可重复的方法,通过葡聚糖G - 15柱色谱法分离尿毒症血清组分。该技术无需预先进行脱蛋白处理,且在室温下进行,能够将尿毒症血清分离成几个界限分明的组分。随后的薄层色谱法(TLC)表明,每个峰代表肽的混合物,并且正常人和尿毒症患者的血浆之间以及急性肾衰竭和慢性肾衰竭患者之间存在定性和定量差异。

相似文献

1
Chromatographic studies of uremic plasma.尿毒症血浆的色谱研究。
Int J Artif Organs. 1979 Jul;2(4):187-91.
2
[Approach to elaborating immunochemical methods for removing peptides from the blood of kidney failure patients].[阐述用于清除肾衰竭患者血液中肽的免疫化学方法的途径]
Biull Eksp Biol Med. 1984 Aug;98(8):245-7.
3
Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.尿毒症血清低分子量组分对蛙皮跨上皮钠转运的抑制作用。
J Clin Invest. 1971 Feb;50(2):303-11. doi: 10.1172/JCI106495.
4
Technical aspects on middle molecules: separation, isolation, and identification.
Artif Organs. 1981;4 Suppl:8-12.
5
Medium-sized peptides in the blood of patients with uremia.尿毒症患者血液中的中等大小肽。
Nephron. 1983;33(4):232-7. doi: 10.1159/000182959.
6
Erythropoietic inhibitors in uremic serum.尿毒症血清中的红细胞生成抑制剂。
Clin Invest Med. 1982;5(4):237-40.
7
Determination of endogenous middle molecules in normal and uremic body fluids.
Clin Nephrol. 1976 Apr;3(2):178-88.
8
[Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].[应用高效液相色谱法和薄层层析法对尿毒症患者血浆中分子质量组分的研究]
Vopr Med Khim. 1988 Nov-Dec;34(6):23-6.
9
All products of proglucagon are elevated in plasma from uremic patients.尿毒症患者血浆中胰高血糖素原的所有产物水平均升高。
J Clin Endocrinol Metab. 1992 Feb;74(2):379-84. doi: 10.1210/jcem.74.2.1730817.
10
Cortisol binding in uremic plasma. II. Decreased cortisol binding to albumin.尿毒症血浆中的皮质醇结合。II. 皮质醇与白蛋白的结合减少。
Nephron. 1984;37(4):229-31. doi: 10.1159/000183254.